Targeting fusion proteins: a double edge sword?-Reference-Cited by-同舟云学术

Targeting fusion proteins: a double edge sword?

Published:2019-06-06 Issue:8 Volume:23 Page:651-654
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Tirado Oscar M.¹²

Affiliation:

1. Sarcoma Research Group, Oncobell Program, Bellvitge Biomedical Research Institute-Catalan Institute of Oncology (IDIBELL-ICO), L’Hospitalet de Llobregat, Barcelona, Spain

2. CIBERONC, Carlos III Institute of Health (ISCIII), Madrid, Spain

Funder

Instituto de Salud Carlos III

Fundación Alba Pérez lucha contra el cancer infantil

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2019.1628219

Reference25 articles.

1. Advances in chromosomal translocations and fusion genes in sarcomas and potential therapeutic applications

2. Biology and Therapy of Dominant Fusion Oncoproteins Involving Transcription Factor and Chromatin Regulators in Sarcomas

3. Bone Sarcomas: From Biology to Targeted Therapies

4. Recent advances in the molecular pathogenesis of Ewing's sarcoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combinatorial strategies to potentiate the efficacy of HDAC inhibitors in fusion-positive sarcomas;Biochemical Pharmacology;2022-04

2. Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-12

3. Molecular mechanisms underpinning sarcomas and implications for current and future therapy;Signal Transduction and Targeted Therapy;2021-06-30